Filing Details
- Accession Number:
- 0001127602-20-028232
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-05 15:51:07
- Reporting Period:
- 2020-03-23
- Accepted Time:
- 2020-11-05 15:51:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1100682 | Charles River Laboratories International Inc. | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1688104 | D William Barbo | 251 Ballardvale Street Wilmington MA 01887 | Corporate Executive Vp & Cco | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-03-23 | 12,151 | $0.00 | 5,899 | No | 5 | G | Direct | |
Common Stock | Acquisiton | 2020-03-23 | 12,151 | $0.00 | 12,151 | No | 5 | G | Indirect | By Trust |
Common Stock | Disposition | 2020-10-30 | 180 | $0.00 | 11,971 | No | 5 | G | Indirect | By Trust |
Common Stock | Disposition | 2020-11-03 | 2,150 | $236.29 | 9,821 | No | 4 | S | Indirect | By Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | G | Direct | |
No | 5 | G | Indirect | By Trust |
No | 5 | G | Indirect | By Trust |
No | 4 | S | Indirect | By Trust |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $236.267 to $236.361. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.